Drug targets hard-to-reach leukemia stem cells responsible for relapses
Friday, January 18, 2013 - 07:00
in Biology & Nature
Researchers have discovered that hard-to-reach, drug-resistant leukemia stem cells (LSCs) that overexpress multiple pro-survival protein forms are sensitive – and thus vulnerable – to a novel cancer stem cell-targeting drug currently under development.